Skip to main content

Advertisement

SpringerLink
Log in

Does Zinc Really “Metal” with Diabetes? The Epidemiologic Evidence

  • Diabetes Epidemiology (NM Maruthur, Section Editor)
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Zinc (Zn) is important in a number of processes related to insulin secretion and insulin activity in peripheral tissues, making this element an interesting potential co-adjuvant in the treatment of patients with type 2 diabetes (T2D). This issue has been matter of interest in recent years. The available evidence is analyzed in this review. Information from epidemiologic studies evaluating the relationship between Zn and T2D is inconsistent. Furthermore, few studies examined the association between Zn status and insulin action and/or glucose homeostasis. In terms of usefulness of Zn as a preventive agent for T2D development, information is insufficient to reach firm conclusions. Results from Zn supplementation trials found some positive effects only in those with initial sub normal Zn status in a significant proportion of individuals. In conclusion, the effect of Zn on patients with type 2 diabetes is still an open question, and better study designs are needed to clarify the real impact and characteristics of the Zn–diabetes interaction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37 Suppl 1:S81–90. doi:10.2337/dc14-S081.

    Article  Google Scholar 

  2. American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care. 2016;39 Suppl 1:S13–22. doi:10.2337/dc16-S005.

    Google Scholar 

  3. Chimienti F, Devergnas S, Favier A, Seve M. Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes. 2004;53(9):2330–7.

    Article  CAS  PubMed  Google Scholar 

  4. Chimienti F, Devergnas S, Pattou F, Schuit F, Garcia-Cuenca R, Vandewalle B, et al. In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion. J Cell Sci. 2006;119(Pt 20):4199–206. doi:10.1242/jcs.03164.

    Article  CAS  PubMed  Google Scholar 

  5. Frayling TM. Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet. 2007;8(9):657–62. doi:10.1038/nrg2178.

    Article  CAS  PubMed  Google Scholar 

  6. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007;445(7130):881–5. doi:10.1038/nature05616.

    Article  CAS  PubMed  Google Scholar 

  7. Maret W. Zinc biochemistry: from a single zinc enzyme to a key element of life. Adv Nutr. 2013;4(1):82–91. doi:10.3945/an.112.003038.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. King JC, Brown KH, Gibson RS, Krebs NF, Lowe NM, Siekmann JH, et al. Biomarkers of nutrition for development (BOND)-zinc review. J Nutr. 2016. doi:10.3945/jn.115.220079.

    Google Scholar 

  9. Ruz M. Zinc: properties and determination. In: Trugo L, Finglas PM, Caballero B, editors. Encyclopedia of food sciences and nutrition. 2nd ed. London: Academic Press; 2003. p. 6267–72.

    Chapter  Google Scholar 

  10. Foster M, Samman S. Zinc and redox signaling: perturbations associated with cardiovascular disease and diabetes mellitus. Antioxid Redox Signal. 2010;13(10):1549–73. doi:10.1089/ars.2010.3111.

    Article  CAS  PubMed  Google Scholar 

  11. Haase H, Rink L. Functional significance of zinc-related signaling pathways in immune cells. Annu Rev Nutr. 2009;29:133–52. doi:10.1146/annurev-nutr-080508-141119.

    Article  CAS  PubMed  Google Scholar 

  12. Kelleher SL, McCormick NH, Velasquez V, Lopez V. Zinc in specialized secretory tissues: roles in the pancreas, prostate, and mammary gland. Adv Nutr. 2011;2(2):101–11. doi:10.3945/an.110.000232.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Ruz M, Cavan KR, Bettger WJ, Thompson L, Berry M, Gibson RS. Development of a dietary model for the study of mild zinc deficiency in humans and evaluation of some biochemical and functional indices of zinc status. Am J Clin Nutr. 1991;53(5):1295–303.

    CAS  PubMed  Google Scholar 

  14. Lowe NM, Fekete K, Decsi T. Methods of assessment of zinc status in humans: a systematic review. Am J Clin Nutr. 2009;89(6):2040S–51. doi:10.3945/ajcn.2009.27230G.

    Article  CAS  PubMed  Google Scholar 

  15. King JC. Zinc: an essential but elusive nutrient. Am J Clin Nutr. 2011;94(2):679S–84. doi:10.3945/ajcn.110.005744.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Ruz M, Carrasco F, Rojas P, Codoceo J, Inostroza J, Basfi-fer K, et al. Zinc as a potential coadjuvant in therapy for type 2 diabetes. Food Nutr Bull. 2013;34(2):215–21.

    Article  PubMed  Google Scholar 

  17. Emdin SO, Dodson GG, Cutfield JM, Cutfield SM. Role of zinc in insulin biosynthesis. Some possible zinc-insulin interactions in the pancreatic B-cell. Diabetologia. 1980;19(3):174–82.

    Article  CAS  PubMed  Google Scholar 

  18. Zhou H, Zhang T, Harmon JS, Bryan J, Robertson RP. Zinc, not insulin, regulates the rat alpha-cell response to hypoglycemia in vivo. Diabetes. 2007;56(4):1107–12. doi:10.2337/db06-1454.

    Article  CAS  PubMed  Google Scholar 

  19. Ishihara H, Maechler P, Gjinovci A, Herrera PL, Wollheim CB. Islet beta-cell secretion determines glucagon release from neighbouring alpha-cells. Nat Cell Biol. 2003;5(4):330–5. doi:10.1038/ncb951.

    Article  CAS  PubMed  Google Scholar 

  20. Tamaki M, Fujitani Y, Hara A, Uchida T, Tamura Y, Takeno K, et al. The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance. J Clin Invest. 2013;123(10):4513–24. doi:10.1172/JCI68807.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Simon SF, Taylor CG. Dietary zinc supplementation attenuates hyperglycemia in db/db mice. Exp Biol Med (Maywood). 2001;226(1):43–51.

    CAS  Google Scholar 

  22. Moustafa SA. Zinc might protect oxidative changes in the retina and pancreas at the early stage of diabetic rats. Toxicol Appl Pharmacol. 2004;201(2):149–55. doi:10.1016/j.taap.2004.05.014.

    Article  CAS  PubMed  Google Scholar 

  23. Wijesekara N, Chimienti F, Wheeler MB. Zinc, a regulator of islet function and glucose homeostasis. Diabetes Obes Metab. 2009;11 Suppl 4:202–14. doi:10.1111/j.1463-1326.2009.01110.x.

    Article  CAS  PubMed  Google Scholar 

  24. Wijesekara N, Dai FF, Hardy AB, Giglou PR, Bhattacharjee A, Koshkin V, et al. Beta cell-specific Znt8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion. Diabetologia. 2010;53(8):1656–68. doi:10.1007/s00125-010-1733-9.

    Article  CAS  PubMed  Google Scholar 

  25. Kahmann L, Uciechowski P, Warmuth S, Plumakers B, Gressner AM, Malavolta M, et al. Zinc supplementation in the elderly reduces spontaneous inflammatory cytokine release and restores T cell functions. Rejuvenation Res. 2008;11(1):227–37. doi:10.1089/rej.2007.0613.

    Article  CAS  PubMed  Google Scholar 

  26. Jansen J, Karges W, Rink L. Zinc and diabetes—clinical links and molecular mechanisms. J Nutr Biochem. 2009;20(6):399–417. doi:10.1016/j.jnutbio.2009.01.009.

    Article  CAS  PubMed  Google Scholar 

  27. Chen H, Carlson EC, Pellet L, Moritz JT, Epstein PN. Overexpression of metallothionein in pancreatic beta-cells reduces streptozotocin-induced DNA damage and diabetes. Diabetes. 2001;50(9):2040–6.

    Article  CAS  PubMed  Google Scholar 

  28. Vardatsikos G, Pandey NR, Srivastava AK. Insulino-mimetic and anti-diabetic effects of zinc. J Inorg Biochem. 2013;120:8–17. doi:10.1016/j.jinorgbio.2012.11.006. An interesting review that explains the mechanisms by which zinc exerts its beneficial effects in type 2 diabetes.

    Article  CAS  PubMed  Google Scholar 

  29. Kinlaw WB, Levine AS, Morley JE, Silvis SE, McClain CJ. Abnormal zinc metabolism in type II diabetes mellitus. Am J Med. 1983;75(2):273–7.

    Article  CAS  PubMed  Google Scholar 

  30. Feng W, Cui X, Liu B, Liu C, Xiao Y, Lu W, et al. Association of urinary metal profiles with altered glucose levels and diabetes risk: a population-based study in China. PLoS ONE. 2015;10(4):e0123742. doi:10.1371/journal.pone.0123742.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Basaki M, Saeb M, Nazifi S, Shamsaei HA. Zinc, copper, iron, and chromium concentrations in young patients with type 2 diabetes mellitus. Biol Trace Elem Res. 2012;148(2):161–4. doi:10.1007/s12011-012-9360-6.

    Article  CAS  PubMed  Google Scholar 

  32. Forte G, Bocca B, Peruzzu A, Tolu F, Asara Y, Farace C, et al. Blood metals concentration in type 1 and type 2 diabetics. Biol Trace Elem Res. 2013;156(1-3):79–90. doi:10.1007/s12011-013-9858-6.

    Article  CAS  PubMed  Google Scholar 

  33. Yerlikaya FH, Toker A, Aribas A. Serum trace elements in obese women with or without diabetes. Indian J Med Res. 2013;137(2):339–45. An interesting work that highlights the importance of BMI as a confounding variable in the analysis of the relationship between zinc and diabetes.

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Islam MR, Arslan I, Attia J, McEvoy M, McElduff P, Basher A, et al. Is serum zinc level associated with prediabetes and diabetes?: a cross-sectional study from Bangladesh. PLoS ONE. 2013;8(4):e61776. doi:10.1371/journal.pone.0061776.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Vashum KP, McEvoy M, Milton AH, Islam MR, Hancock S, Attia J. Is serum zinc associated with pancreatic beta cell function and insulin sensitivity in pre-diabetic and normal individuals? Findings from the Hunter Community Study. PLoS ONE. 2014;9(1):e83944. doi:10.1371/journal.pone.0083944.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Dosa MD, Hangan LT, Crauciuc E, Gales C, Nechifor M. Influence of therapy with metformin on the concentration of certain divalent cations in patients with non-insulin-dependent diabetes mellitus. Biol Trace Elem Res. 2011;142(1):36–46. doi:10.1007/s12011-010-8751-9.

    Article  CAS  PubMed  Google Scholar 

  37. Tubek S. Gender differences in selected zinc metabolism parameters in patients with mild primary arterial hypertension. Biol Trace Elem Res. 2006;114(1-3):55–63. doi:10.1385/BTER:114:1:55.

    Article  CAS  PubMed  Google Scholar 

  38. Tubek S. Selected zinc metabolism parameters in relation to insulin, renin-angiotensin-aldosterone system, and blood pressure in healthy subjects: gender differences. Biol Trace Elem Res. 2006;114(1-3):65–72. doi:10.1385/BTER:114:1:65.

    Article  CAS  PubMed  Google Scholar 

  39. Shan Z, Bao W, Zhang Y, Rong Y, Wang X, Jin Y, et al. Interactions between zinc transporter-8 gene (SLC30A8) and plasma zinc concentrations for impaired glucose regulation and type 2 diabetes. Diabetes. 2014;63(5):1796–803. doi:10.2337/db13-0606.

    Article  CAS  PubMed  Google Scholar 

  40. Vashum KP, McEvoy M, Shi Z, Milton AH, Islam MR, Sibbritt D, et al. Is dietary zinc protective for type 2 diabetes? Results from the Australian longitudinal study on women’s health. BMC Endocr Disord. 2013;13:40. doi:10.1186/1472-6823-13-40.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Sun Q, van Dam RM, Willett WC, Hu FB. Prospective study of zinc intake and risk of type 2 diabetes in women. Diabetes Care. 2009;32(4):629–34. doi:10.2337/dc08-1913.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. de Oliveira Otto MC, Alonso A, Lee DH, Delclos GL, Bertoni AG, Jiang R, et al. Dietary intakes of zinc and heme iron from red meat, but not from other sources, are associated with greater risk of metabolic syndrome and cardiovascular disease. J Nutr. 2012;142(3):526–33. doi:10.3945/jn.111.149781.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Song Y, Xu Q, Park Y, Hollenbeck A, Schatzkin A, Chen H. Multivitamins, individual vitamin and mineral supplements, and risk of diabetes among older U.S. adults. Diabetes Care. 2011;34(1):108–14. doi:10.2337/dc10-1260.

    Article  PubMed  Google Scholar 

  44. Kanoni S, Nettleton JA, Hivert MF, Ye Z, van Rooij FJ, Shungin D, et al. Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-cohort meta-analysis. Diabetes. 2011;60(9):2407–16. doi:10.2337/db11-0176.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Maruthur NM, Clark JM, Fu M, Linda Kao WH, Shuldiner AR. Effect of zinc supplementation on insulin secretion: interaction between zinc and SLC30A8 genotype in Old Order Amish. Diabetologia. 2015;58(2):295–303. doi:10.1007/s00125-014-3419-1.

    Article  CAS  PubMed  Google Scholar 

  46. Billings LK, Jablonski KA, Ackerman RJ, Taylor A, Fanelli RR, McAteer JB, et al. The influence of rare genetic variation in SLC30A8 on diabetes incidence and beta-cell function. J Clin Endocrinol Metab. 2014;99(5):E926–30. doi:10.1210/jc.2013-2378.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Flannick J, Thorleifsson G, Beer NL, Jacobs SB, Grarup N, Burtt NP, et al. Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nat Genet. 2014;46(4):357–63. doi:10.1038/ng.2915. This work found a decreased risk of type 2 diabetes in people with loss-of-function variants of ZnT-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. El Dib R, Gameiro OL, Ogata MS, Modolo NS, Braz LG, Jorge EC, et al. Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance. Cochrane Database Syst Rev. 2015;5:CD005525. doi:10.1002/14651858.CD005525.pub3.

    Google Scholar 

  49. Jayawardena R, Ranasinghe P, Galappatthy P, Malkanthi R, Constantine G, Katulanda P. Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr. 2012;4(1):13. doi:10.1186/1758-5996-4-13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Capdor J, Foster M, Petocz P, Samman S. Zinc and glycemic control: a meta-analysis of randomised placebo controlled supplementation trials in humans. J Trace Elem Med Biol. 2013;27(2):137–42. doi:10.1016/j.jtemb.2012.08.001. The latest meta-analysis on zinc supplementation and diabetes.

    Article  CAS  PubMed  Google Scholar 

  51. Gupta R, Garg VK, Mathur DK, Goyal RK. Oral zinc therapy in diabetic neuropathy. J Assoc Physicians India. 1998;46(11):939–42.

    CAS  PubMed  Google Scholar 

  52. Hayee MA, Mohammad QD, Haque A. Diabetic neuropathy and zinc therapy. Bangladesh Med Res Counc Bull. 2005;31(2):62–7.

    CAS  PubMed  Google Scholar 

  53. Hegazi SM, Ahmed SS, Mekkawy AA, Mortagy MS, Abdel-Kadder M. Effect of zinc supplementation on serum glucose, insulin, glucagon, glucose-6-phosphatase, and mineral levels in diabetics. J Clin Biochem Nutr. 1992;12(3):209–15. doi:10.3164/jcbn.12.209.

    Article  CAS  Google Scholar 

  54. Hussain SA, Khadim HM, Khalaf BH, Ismail SH, Hussein KI, Sahib AS. Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin. Saudi Med J. 2006;27(10):1483–8.

    PubMed  Google Scholar 

  55. Parham M, Amini M, Aminorroaya A, Heidarian E. Effect of zinc supplementation on microalbuminuria in patients with type 2 diabetes: a double blind, randomized, placebo-controlled, cross-over trial. Rev Diabet Stud. 2008;5(2):102–9. doi:10.1900/RDS.2008.5.102.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Partida-Hernandez G, Arreola F, Fenton B, Cabeza M, Roman-Ramos R, Revilla-Monsalve MC. Effect of zinc replacement on lipids and lipoproteins in type 2-diabetic patients. Biomed Pharmacother. 2006;60(4):161–8. doi:10.1016/j.biopha.2006.02.004.

    Article  CAS  PubMed  Google Scholar 

  57. Seet RC, Lee CY, Lim EC, Quek AM, Huang H, Huang SH, et al. Oral zinc supplementation does not improve oxidative stress or vascular function in patients with type 2 diabetes with normal zinc levels. Atherosclerosis. 2011;219(1):231–9. doi:10.1016/j.atherosclerosis.2011.07.097.

    Article  CAS  PubMed  Google Scholar 

  58. Afkhami-Ardekani M, Karimi M, Mohammadi SM, Nourani F. Effect of zinc sulfate supplementation on lipid and glucose in type 2 diabetic patients. Pak J Nutr. 2008;7. doi:10.3923/pjn.2008.550.553

  59. Al-Maroof RA, Al-Sharbatti SS. Serum zinc levels in diabetic patients and effect of zinc supplementation on glycemic control of type 2 diabetics. Saudi Med J. 2006;27(3):344–50.

    PubMed  Google Scholar 

  60. Farvid MS, Jalali M, Siassi F, Hosseini M. Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes. Diabetes Care. 2005;28(10):2458–64.

    Article  PubMed  Google Scholar 

  61. Farvid MS, Homayouni F, Amiri Z, Adelmanesh F. Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation. Diabetes Res Clin Pract. 2011;93(1):86–94. doi:10.1016/j.diabres.2011.03.016.

    Article  CAS  PubMed  Google Scholar 

  62. Gunasekara P, Hettiarachchi M, Liyanage C, Lekamwasam S. Effects of zinc and multimineral vitamin supplementation on glycemic and lipid control in adult diabetes. Diabetes Metab Syndr Obes. 2011;4:53–60. doi:10.2147/DMSO.S16691.

    CAS  PubMed  PubMed Central  Google Scholar 

  63. Oh HM, Yoon JS. Glycemic control of type 2 diabetic patients after short-term zinc supplementation. Nutr Res Pract. 2008;2(4):283–8. doi:10.4162/nrp.2008.2.4.283.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Kajanachumpol S, Srisurapanon S, Supanit I, Roongpisuthipong C, Apibal S. Effect of zinc supplementation on zinc status, copper status and cellular immunity in elderly patients with diabetes mellitus. J Med Assoc Thai. 1995;78(7):344–9.

    CAS  PubMed  Google Scholar 

  65. Foster M, Chu A, Petocz P, Samman S. Zinc transporter gene expression and glycemic control in post-menopausal women with type 2 diabetes mellitus. J Trace Elem Med Biol. 2014;28(4):448–52. doi:10.1016/j.jtemb.2014.07.012.

    Article  CAS  PubMed  Google Scholar 

  66. Foster M, Karra M, Picone T, Chu A, Hancock DP, Petocz P, et al. Dietary fiber intake increases the risk of zinc deficiency in healthy and diabetic women. Biol Trace Elem Res. 2012;149(2):135–42. doi:10.1007/s12011-012-9408-7.

    Article  CAS  PubMed  Google Scholar 

  67. Lima VBS, Sampaio FA, Bezerra DLC, Moita Neto JM, Marreiro DN. Parameters of glycemic control and their relationship with zinc concentrations in blood and with superoxide dismutase enzyme activity in type 2 diabetes patients. Arq Bras Endocrinol Metab. 2011;55:701–7.

    Article  Google Scholar 

  68. Ferdousi S, Mollah F, Mia M. Serum levels of zinc and magnesium in newly diagnosed type-2 diabetic subjects. Bangladesh J Med Biochem. 2010;3(2):46–9. doi:10.3329/bjmb.v3i2.13811.

    Google Scholar 

  69. Xu J, Zhou Q, Liu G, Tan Y, Cai L. Analysis of serum and urinal copper and zinc in Chinese northeast population with the prediabetes or diabetes with and without complications. Oxid Med Cell Longev. 2013;2013:635214. doi:10.1155/2013/635214.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Rahim A, Iqbal K. To assess the levels of zinc in serum and changes in the lens of diabetic and senile cataract patients. J Pak Med Assoc. 2011;61(9):853–5.

    PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank support from the National Fund for Science and Technology, FONDECYT grant 1160792 (MR, FC, AS, and PR), and from the National Council for Science and Technology (CONICYT) Doctorate program (AP).

Author information

Authors and Affiliations

  1. Department of Nutrition, Faculty of Medicine, University of Chile, Independencia 1027, Postal Code 8380453, Santiago, Chile

    Manuel Ruz, Fernando Carrasco, Andrés Sánchez, Alvaro Perez & Pamela Rojas

Authors
  1. Manuel Ruz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fernando Carrasco
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrés Sánchez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alvaro Perez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pamela Rojas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manuel Ruz.

Ethics declarations

Conflict of Interest

Manuel Ruz, Fernando Carrasco, Andrés Sánchez, Alvaro Perez, and Pamela Rojas declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Diabetes Epidemiology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ruz, M., Carrasco, F., Sánchez, A. et al. Does Zinc Really “Metal” with Diabetes? The Epidemiologic Evidence. Curr Diab Rep 16, 111 (2016). https://doi.org/10.1007/s11892-016-0803-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11892-016-0803-x

Keywords

Search

Navigation